Our task force leads Karen Yuen and Sui Wong joined the “World Rare Disease Day 2020 Online Symposium” organized by Rare Disease Hong Kong (RDHK), formerly known as “Hong Kong Alliance for Rare Diseases (HKARD)”.
HKAPI submits an opinion paper, on behalf of its 33 member companies engaging in the research and development of novel pharmaceuticals, and providing 70% of treatment drugs in Hong Kong.
HKAPI statement on Novel Coronavirus The Hong Kong Association of the pharmaceutical Industry (HKAPI) representing 34 R&D multinational pharmaceutical companies in Hong Kong, providing 70% of prescription medicine in Hong […]
To share findings from a recently conducted Patient Support Program research and to build a platform for stakeholders to exchange point of view, the HKAPI organized a sharing session for member companies and their collaborating partners on May 17, 2019.
On 23 March 2019, over 30 Macao stakeholders participated in the Macao Roundtable on Improving Patient Access, the first ever face-to-face discussion on healthcare issues between the industry and Macao policy-makers in a roundtable setting.
On 23rd February 2019, the Hong Kong Alliance of Patients’ Organization, the Hospital Authority and the HKAPI Joined hands to organise the sixth Patient Empowerment forum. Over 150 patients, healthcare professionals and HKAPI members participated in the event.
Over 60 patients , representative from Hong Kong’s Legislative Council and HKAPI members gathered for the Patient Empowerment Workshop organized on 24 March 2018.